Glial fibrillary acidic protein as a serum neuromarker of brain injury in pediatric patients with congenital heart defects undergoing cardiac surgery
Objective: The aim of this study was to assess glial fibrillary acidic protein (GFAP) as a marker of short-term neurodevelopmental delay in pediatric patients with congenital defects (CHD) after cardiovascular surgical intervention.
Main Authors: | Chiperi Lacramioara-Eliza, Huţanu Adina |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-09-01
|
Series: | Acta Marisiensis - Seria Medica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amma-2023-0037 |
Similar Items
-
Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
by: Lacramioara Eliza Chiperi, et al.
Published: (2023-10-01) -
Glial Fibrillary Acidic Protein: Diagnostic and Prognostic Role in Psychomotor Development Dynamics in Patients with Congenital Heart Defects after Cardiovascular Surgery
by: Lacramioara Eliza Chiperi, et al.
Published: (2024-03-01) -
Clinical Features of Multicenter Autoimmune Glial Fibrillary Acidic Protein Astrocytosis
by: ZHENG Xiujun, et al.
Published: (2022-04-01) -
Perioperative Glial Fibrillary Acidic Protein Is Associated with Long-Term Neurodevelopment Outcome of Infants with Congenital Heart Disease
by: Michela Vergine, et al.
Published: (2021-07-01) -
Glial Fibrillary Acidic Protein Astrocytopathy in Pediatric Patients: A Retrospective Study
by: Haixia Huang, et al.
Published: (2021-01-01)